tiprankstipranks
Trending News
More News >
Dr. Agarwal's Health Care Ltd. (IN:AGARWALEYE)
:AGARWALEYE
India Market

Dr. Agarwal's Health Care Ltd. (AGARWALEYE) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

AGARWALEYE Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Dr.
Agarwal's Health Care Ltd.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AGARWALEYE Stock 12 Month Forecast

There Are No Analyst Ratings for IN:AGARWALEYE In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

AGARWALEYE Financial Forecast

AGARWALEYE Earnings Forecast

Next quarter’s earnings estimate for AGARWALEYE is ₹1.00 with a range of ₹1.00 to ₹1.00. The previous quarter’s EPS was ₹1.10. AGARWALEYE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year AGARWALEYE has Performed in-line its overall industry.
Next quarter’s earnings estimate for AGARWALEYE is ₹1.00 with a range of ₹1.00 to ₹1.00. The previous quarter’s EPS was ₹1.10. AGARWALEYE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year AGARWALEYE has Performed in-line its overall industry.

AGARWALEYE Sales Forecast

Next quarter’s sales forecast for AGARWALEYE is ₹5.32B with a range of ₹5.32B to ₹5.32B. The previous quarter’s sales results were ₹5.30B. AGARWALEYE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year AGARWALEYE has Performed in-line its overall industry.
Next quarter’s sales forecast for AGARWALEYE is ₹5.32B with a range of ₹5.32B to ₹5.32B. The previous quarter’s sales results were ₹5.30B. AGARWALEYE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year AGARWALEYE has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - DeepSeek Analyst forecast on IN:AGARWALEYE
TipRanks - DeepSeek
TipRanks - DeepSeek
₹460₹466
Hold
-6.80%
Downside
Reiterated
03/19/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on IN:AGARWALEYE
TipRanks - Anthropic
TipRanks - Anthropic
₹471₹477
Buy
-4.60%
Downside
Initiated
03/19/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on IN:AGARWALEYE
TipRanks - Google
TipRanks - Google
₹443₹449
Hold
-10.20%
Downside
Reiterated
03/19/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on IN:AGARWALEYE
TipRanks - PerPlexity
TipRanks - PerPlexity
₹456₹462
Hold
-7.60%
Downside
Reiterated
03/19/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on IN:AGARWALEYE
TipRanks - xAI
TipRanks - xAI
₹473₹479
Buy
-4.20%
Downside
Reiterated
03/19/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on IN:AGARWALEYE
TipRanks - OpenAI
TipRanks - OpenAI
₹478₹483
Buy
-3.40%
Downside
Reiterated
03/19/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - DeepSeek Analyst forecast on IN:AGARWALEYE
TipRanks - DeepSeek
TipRanks - DeepSeek
₹460₹466
Hold
-6.80%
Downside
Reiterated
03/19/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on IN:AGARWALEYE
TipRanks - Anthropic
TipRanks - Anthropic
₹471₹477
Buy
-4.60%
Downside
Initiated
03/19/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on IN:AGARWALEYE
TipRanks - Google
TipRanks - Google
₹443₹449
Hold
-10.20%
Downside
Reiterated
03/19/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on IN:AGARWALEYE
TipRanks - PerPlexity
TipRanks - PerPlexity
₹456₹462
Hold
-7.60%
Downside
Reiterated
03/19/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on IN:AGARWALEYE
TipRanks - xAI
TipRanks - xAI
₹473₹479
Buy
-4.20%
Downside
Reiterated
03/19/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on IN:AGARWALEYE
TipRanks - OpenAI
TipRanks - OpenAI
₹478₹483
Buy
-3.40%
Downside
Reiterated
03/19/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dr. Agarwal's Health Care Ltd.

3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+15.20%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +15.20% per trade.
1 Year
Anthropic Health Care INTipRanks - Anthropic
Success Rate
0/1 ratings generated profit
0%
Average Return
0.00%
Copying Anthropic Health Care IN's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
0.00%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AGARWALEYE Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, AGARWALEYE has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AGARWALEYE average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

AGARWALEYE Stock Forecast FAQ

What is IN:AGARWALEYE’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:AGARWALEYE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:AGARWALEYE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Dr. Agarwal's Health Care Ltd. a Buy, Sell or Hold?
      Currently, no data Available
      What is Dr. Agarwal's Health Care Ltd.’s share price target?
      Currently, no data Available
      What do analysts say about Dr. Agarwal's Health Care Ltd.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Dr. Agarwal's Health Care Ltd.?
      To buy shares of IN:AGARWALEYE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.